Single Anti-Platelet Therapy versus Dual Anti-Platelet Therapy after Transcatheter Aortic Valve Replacement: A Meta-Analysis

References

• Khatri PJ , Webb JG , Rodes-Cabau J , et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med . 2013;158:35–46. doi:10.7326/0003-4819-158-1-201301010-00007.
   PubMed Web of Science ®Google Scholar
• Leon MB , Smith CR , Mack MJ , et al., for the PARTNER 2 Investigators. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med . 2016;374:1609–1620. doi:10.1056/NEJMoa1514616.
   PubMed Web of Science ®Google Scholar
• Kodali SK , Williams MR , Smith CR , et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med . 2012;366:1686–1695. doi:10.1056/NEJMoa1200384.
   PubMed Web of Science ®Google Scholar
• Nishimura RA , Otto CM , Bonow RO , et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thoracic Cardiovasc Surg . 2014;148:e1–e132. doi:10.1016/j.jtcvs.2014.05.014.
   PubMed Web of Science ®Google Scholar
• Leon MB , Smith CR , Mack M , et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med . 2010;363:1597–1607. doi:10.1056/NEJMoa1008232.
   PubMed Web of Science ®Google Scholar
• Tamburino C , Capodanno D , Ramondo A , et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation . 2011;123:299–308. doi:10.1161/CIRCULATIONAHA.110.946533.
   PubMed Web of Science ®Google Scholar
• Czerwinska-Jelonkiewicz K , Witkowski A , Dabrowski M , et al. Antithrombotic therapy – predictor of early and long-term bleeding complications after transcatheter aortic valve implantation. Arch Med Sci . 2013;9:1062–1070. doi:10.5114/aoms.2013.39794.
   Web of Science ®Google Scholar
• Ichibori Y , Mizote I , Maeda K , et al. Clinical outcomes and bioprosthetic valve function after transcatheter aortic valve implantation under dual antiplatelet therapy vs. aspirin alone. Circ J . 2017;81:397–404. doi:10.1253/circj.CJ-16-0903.
   Web of Science ®Google Scholar
• Czerwinska-Jelonikiewicz K , Zembala M , Dabrowski M , et al. Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry-POL-TAVI. Int J Cardiol . 2017;227:305–311. doi:10.1016/j.ijcard.2016.11.095.
   Web of Science ®Google Scholar
• Mangieri A , Jabbour RJ , Montalto C , et al. Single-antiplatelet therapy in patients with contraindication to dual-antiplatelet therapy after transcatheter aortic valve implantation. Am J Cardiol . 2017;119:1088–1093. doi:10.1016/j.amjcard.2016.11.065.
   PubMed Web of Science ®Google Scholar
• Rodés-Cabau J , Masson J-B , Welsh RC , et al. Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE (aspirin versus aspirin + clopidogrel following transcatheter aortic valve implantation) randomized clinical trial. J Am Coll Cardiol Intv . 2017;10:1357–1365.
   Google Scholar
• Ussia GP , Scarabelli M , Mule M , et al. Dual anti platelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol . 2011;108:1772–1776. doi:10.1016/j.amjcard.2011.07.049.
   PubMed Web of Science ®Google Scholar
• Stabile E , Pucciarelli A , Cota L , et al. SAT-TAVI (Single Antiplatelet Therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation. Int J Cardiol . 2014;174:624–627. doi:10.1016/j.ijcard.2014.04.170.
   PubMed Web of Science ®Google Scholar
• Aryal MR , Karmacharya P , Pandit A , et al. Dual versus single antiplatelet therapy in patients undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis. Heart Lung Circ . 2015;24:185–192. doi:10.1016/j.hlc.2014.07.058.
   PubMed Web of Science ®Google Scholar
• Vavuranakis M , Siasos G , Zografos T , et al. Dual or single antiplatelet therapy after transcatheter aortic valve implantation? A systematic review and meta-analysis. Curr Pharm Des . 2016;22:4596–4603. doi:10.2174/1381612822666160601110716.
   Web of Science ®Google Scholar
• Gandhi S , Schwalm JD , Velianou JL , Natarajan MK , Farkouh ME. Comparison of dual-antiplatelet therapy to mono-antiplatelet therapy after transcatheter aortic valve implantation: systematic review and meta-analysis. Can J Cardiol . 2015;31:775–784. doi:10.1016/j.cjca.2015.01.014.
   Web of Science ®Google Scholar
• Hassell MECJ , Hildick-Smith D , Durand E , et al. Antiplatelet therapy following transcatheter aortic valve implantation. Heart . 2015;101:1118–1125. doi:10.1136/heartjnl-2014-307053.
   Google Scholar
• Verdoia M , Barbieri L , Nardin M , Suryapranata H , De Luca G. Dual versus single antiplatelet regimen with or without anticoagulation in transcatheter aortic valve replacement: indirect comparison and meta-analysis. Revista Española De Cardiología (English Edition) . 2018;71(4):257–266. doi:10.1016/j.rec.2017.06.012.
   Web of Science ®Google Scholar
• Ando T , Takagi H , Briasoulis A , Afonso L . Single versus dual anti-platelet therapy post transcatheter aortic valve implantation: a meta-analysis of randomized controlled trials. J Thromb Thrombolysis . 2017;44:448–456. doi:10.1007/s11239-017-1550-9.
   Web of Science ®Google Scholar
• Ahmad Y , Demir O , Rajkumar C , et al. Optimal antiplatelet strategy after transcatheter aortic valve implantation: a meta-analysis. Open Heart . 2018;5:e000748. doi:10.1136/openhrt-2017-000748.
   Web of Science ®Google Scholar
• David M , Alessandro L , Jennifer T , Altman Douglas G . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ . 2009;339:b2535.
   Web of Science ®Google Scholar
• Stroup DF , Berlin JA , Morton SC , et al. Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA . 2000;283(15):2008–2012. doi:10.1001/jama.283.15.2008.
   PubMed Web of Science ®Google Scholar
• Kappetein AP , Head SJ , Généreux P , et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol . 2012;60:1438–1454. doi:10.1016/j.jacc.2012.09.001.
   PubMed Web of Science ®Google Scholar
• Leon MB , Piazza N , Nikolsky E , et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol . 2011;57:253–269. doi:10.1016/j.jacc.2010.12.005.
   PubMed Web of Science ®Google Scholar
• Higgins JP , Altman DG , Gøtzsche PC , et al., Cochrane Bias Methods Group, Cochrane Statistical Methods Group . The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ . 2011;343:d5928. doi:10.1136/bmj.d5928.
   PubMed Web of Science ®Google Scholar
• Lo CK , Mertz D , Loeb M . Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol . 2014;14. doi:10.1186/1471-2288-14-45.
   Web of Science ®Google Scholar
• Higgins JP , Green S . Cochrane Handbook for Systematic Reviews of Inverventions . Baltimore, MD: The Cochrane Collaboration; 2008.
   Google Scholar
• DerSimonian R , Laird N . Meta-analysis in clinical trials. Control Clin Trials . 1986;7:177–188. doi:10.1016/0197-2456(86)90046-2.
   PubMed Web of Science ®Google Scholar
• Yusuf S , Peto R , Lewis J , Collins R , Sleight P . Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis . 1985;27(5):335–371.
   PubMed Web of Science ®Google Scholar
• Egger M , Davey Smith G , Schneider M , et al. Bias in meta-analysis detected by a simple, graphical test. BMJ . 1997;315:629–634. doi:10.1136/bmj.315.7109.629.
   PubMed Web of Science ®Google Scholar
• Higgins JP , Thompson SG , Deeks JJ , Altman DG . Measuring inconsistency in metaanalyses. BMJ . 2003;327:557–560. doi:10.1136/bmj.327.7420.895.
   PubMed Web of Science ®Google Scholar
• Poliacikova P , Cockburn J , De Belder A , et al. Antiplatelet and antithrombotic treatment after transcatheter aortic valve implantation—comparison of regimes. J Invasive Cardiol . 2013;25:544–548.
   PubMed Web of Science ®Google Scholar
• Durand E , Blanchard D , Chassaing S , et al. Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation. Am J Cardiol . 2014;113:355–360. doi:10.1016/j.amjcard.2013.09.033.
   PubMed Web of Science ®Google Scholar
• Huczek Z , Kochman J , Grygier M , et al. Pre-procedural dual antiplatelet therapy and bleeding events following transcatheter aortic valve implantation (TAVI). Thromb Res . 2015;136:112–117. doi:10.1016/j.thromres.2015.11.011.
   Web of Science ®Google Scholar
• Hioki H , Watanabe Y , Kozuma K , et al. Preprocedural dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation increases risk of bleeding. Heart . 2017;103:361–367. doi:10.1136/heartjnl-2016-309735.
   PubMed Web of Science ®Google Scholar
• Rossi JE . Anticoagulation in TAVR. JACC . Mar 17, 2014. http://www.acc.org/latest-in-cardiology/articles/2014/07/18/15/35/anticoagulation-in-tavr.
   Google Scholar
• Rodés-Cabau J , Dauerman HL , Cohen MG , et al. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. J Am Coll Cardiol . 2013;62:2349–2359. doi:10.1016/j.jacc.2013.03.029.
   PubMed Web of Science ®Google Scholar
• Grube E , Laborde JC , Gerckens U , et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first in-man study. Circulation . 2006;114:1616–1624. doi:10.1161/CIRCULATIONAHA.106.639450.
   PubMed Web of Science ®Google Scholar
• Sherwood MW , Vora AN , Vemulapalli S , et al. TCT-103 National variation in post-TAVR antithrombotic therapy utilization and associated outcomes: insights from the STS/ACC TVT Registry [abstract]. J Am Coll Cardiol . 2015;66(15S):B47–B48. doi:10.1016/j.jacc.2015.08.149.
   Web of Science ®Google Scholar
• Smith CR , Leon MB , Mack MJ , et al. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med . 2011;364:2187–2198. doi:10.1056/NEJMoa1007994.
   PubMed Web of Science ®Google Scholar
• Généreux P , Cohen DJ , Mack M , et al. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. J Am Coll Cardiol . 2014:2605–2615. doi:10.1016/j.jacc.2014.08.052.
   Web of Science ®Google Scholar
• Webb J , Rodes-Cabau J , Fremes S , et al. Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement. Can J Cardiol . 2012;28:520–528. doi:10.1016/j.cjca.2012.04.015.
   PubMed Web of Science ®Google Scholar
• Whitlock RP , Sun JC , Fremes SE , Rubens FD , Teoh KH , American College of Chest P . Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest . 2012;141(2 Suppl):e576S–e600S. doi:10.1378/chest.11-2305.
   PubMed Web of Science ®Google Scholar
• Otto CM , Kumbhani DJ , Alexander KP , et al. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol . 2017;69:1313–1346. doi:10.1016/j.jacc.2016.11.026.
   PubMed Web of Science ®Google Scholar
• Mehta SR , Bainey KR , Cantor WJ , et al. Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy. Can J Cardiol . 2018;34(3):214–233. ISSN 0828-282X. doi:10.1016/j.cjca.2017.12.012.
   PubMed Web of Science ®Google Scholar
• Nishimura RA , Otto CM , Bonow RO , et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol . 2017;70:252–289. doi:10.1016/j.jacc.2017.04.053.
   PubMed Web of Science ®Google Scholar
• Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, et al. Guidelines on the management of valvular heart disease. Eur Heart J . 2012;33:2451–2496. doi:10.1093/eurheartj/ehs109.
   PubMed Web of Science ®Google Scholar
• Chakravarty T , Sondergaard L , Friedman J , et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet . 2017;389(10087):2383–2392. doi:10.1016/S0140-6736(17)30757-2.
   PubMed Web of Science ®Google Scholar
• Cribier A , Eltchaninoff H , Tron C , et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol . 2004;43:698–703. doi:10.1016/j.jacc.2003.11.026.
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr. , Mack MJ , Kaul S , et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol . 2012;59:1200–1254. doi:10.1016/j.jacc.2012.01.001.
   PubMed Web of Science ®Google Scholar
• Raheja H , Garg A , Goel S , et al. Comparison of single versus dual antiplatelet therapy after TAVR: a systematic review and meta‐analysis. Catheter Cardiovasc Interv . 2018;00:1–9. doi:10.1002/ccd.27582.
   Web of Science ®Google Scholar